Get the Stockscreener App
2.72
33.99%
0.69
After Hours:
2.69
-0.03
-1.10%
Cerus Corp stock is traded at $2.72, with a volume of 24.77M.
It is up +33.99% in the last 24 hours and up +45.45% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
See More
Previous Close:
$2.03
Open:
$2.69
24h Volume:
24.77M
Relative Volume:
13.31
Market Cap:
$545.00M
Revenue:
$206.13M
Net Income/Loss:
$-15.64M
P/E Ratio:
-32.97
EPS:
-0.0825
Net Cash Flow:
$1.11M
1W Performance:
+37.37%
1M Performance:
+45.45%
6M Performance:
+85.03%
1Y Performance:
+109.23%
1-Day Range:
$2.47
$3.15
1-Week Range:
$1.88
$3.15
52-Week Range:
$1.15
$3.15
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
2.72 | 406.75M | 206.13M | -15.64M | 1.11M | -0.0825 |
ABT
Abbott Laboratories
|
89.46 | 158.14B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
294.73 | 120.69B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
80.00 | 103.96B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
56.50 | 85.62B | 20.62B | 3.56B | 3.66B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.98 | 48.14B | 6.30B | 1.07B | 1.34B | 1.8406 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-24 | Initiated | Craig Hallum | Buy |
| Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-08-20 | Resumed | BTIG Research | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| Feb-26-20 | Initiated | BTIG Research | Buy |
| Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-28-19 | Initiated | Stifel | Buy |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-08-17 | Resumed | BTIG Research | Neutral |
| Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
| Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
| May-02-14 | Reiterated | MLV & Co | Buy |
| Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-15-13 | Reiterated | MLV & Co | Buy |
| Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
| Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-10-11 | Reiterated | MLV & Co | Buy |
| Jun-03-11 | Initiated | Wedbush | Outperform |
| Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
Cerus Corporation Q1 2026 SEC Filing: Financial Statements, Risk Factors, and Management Discussion - Minichart
[144] CERUS CORP SEC Filing - Stock Titan
Insider sale filings: CERS (NASDAQ: CERS) reports restricted stock dispositions - Stock Titan
CERS Upgraded by BTIG -- Price Target Announced at $4.00 - GuruFocus
Cerus (NASDAQ:CERS) Reaches New 12-Month High After Better-Than-Expected Earnings - MarketBeat
Q1 2026 Cerus Corp Earnings Call Transcript - GuruFocus
BTIG Research Upgrades Cerus (NASDAQ:CERS) to "Buy" - MarketBeat
Cerus Corporation (NASDAQ:CERS) Q1 2026 Earnings Call Transcript - Insider Monkey
Cerus Corp (CERS) Q1 2026 Earnings Call Highlights: Strong Reven - GuruFocus
Cerus (NASDAQ:CERS) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Is Cerus (CERS) 8.6% Undervalued After Q1 2026 Earnings Beat? EP - GuruFocus
Cerus Q1 Earnings Call Highlights - MarketBeat
Cerus (NASDAQ: CERS) grows Q1 2026 revenue and sharply cuts net loss - Stock Titan
Earnings call transcript: Cerus Corporation Q1 2026 beats EPS forecast - Investing.com
Cerus Corporation (CERS) Stock Rises on Q1 2026 Earnings - Quiver Quantitative
Cerus Corp (NASDAQ:CERS) Surges on Strong Q1 Beat and Raised Guidance - ChartMill
Cerus: Q1 Earnings Snapshot - KVUE
[8-K] CERUS CORP Reports Material Event - Stock Titan
Cerus Corporation Announces First Quarter 2026 Financial Results - ChartMill
Cerus signs four-year supply deal with French blood service - Investing.com
Cerus signs four-year supply deal with French blood service By Investing.com - Investing.com Canada
Cerus wins 4-year deal with French blood network serving 330,000 units - Stock Titan
Cerus (CERS) to Release Earnings on Thursday - MarketBeat
[ARS] CERUS CORP SEC Filing - Stock Titan
Cerus (NASDAQ: CERS) seeks equity plan approval and board re-election - Stock Titan
Cerus appoints severance agreements for Kevin D. Green, Vivek Jayaraman, Richard Benjamin and Chrystal N. Jensen - TradingView
Cerus (NASDAQ: CERS) sets richer change-of-control severance for executives - Stock Titan
Sumitomo Mitsui Trust Group Inc. Sells 975,218 Shares of Cerus Corporation $CERS - MarketBeat
Cerus sets April 30 earnings release, 4:30 p.m. ET webcast - Stock Titan
Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026 - Yahoo Finance
Cerus (NASDAQ:CERS) Shares Cross Above 200-Day Moving AverageTime to Sell? - MarketBeat
Q3 2025 Cerus Corp Earnings Call Transcript - GuruFocus
Cerus (CERS) CFO receives 200,000-share RSU grant, lifts holdings to 1.24M - Stock Titan
Cerus (CERS) Chief Legal Officer receives 200,000-share RSU stock grant - Stock Titan
Cerus Corp (CU2.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
CERS SEC FilingsCerus 10-K, 10-Q, 8-K Forms - Stock Titan
CERS Technical Analysis & Stock Price Forecast - Intellectia AI
Cerus Corp (CERS) Stock Price Quote Today & Current Price Chart - Capital.com
Vanguard disaggregates holdings after realignment; Cerus Corp (NASDAQ: CERS) - Stock Titan
Soleus Capital (NASDAQ: CERS) discloses 5.1% position in Cerus - Stock Titan
Aug Shorts: Is Cerus Corporation in accumulation or distribution phase2026 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
Wall Street Recap: What is the PEG ratio of Cerus Corporation2026 Technical Patterns & Detailed Earnings Play Strategies - baoquankhu1.vn
Vivek Jayaraman Sells 165,200 Shares of Cerus (NASDAQ:CERS) Stock - Defense World
Cerus Appoints Vivek Jayaraman As Chief Executive Officer - citybiz
Cerus Corp: chief medical officer Benjamin sells $168k in shares - Investing.com Nigeria
Cerus names COO Vivek Jayaraman as next CEO effective July 1 By Investing.com - Investing.com South Africa
Cerus Corp: chief medical officer Benjamin sells $168k in shares By Investing.com - Investing.com South Africa
Cerus CFO Kevin Green sells $169k in shares - Investing.com Nigeria
Cerus Corp CFO green sells $211k in shares - Investing.com
Cerus Corp CEO Greenman sells $742k in shares By Investing.com - Investing.com Canada
Cerus Corp CEO Greenman sells $742k in shares - Investing.com Nigeria
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cerus Corp Stock (CERS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Greenman William Mariner | President and CEO |
Mar 12 '26 |
Sale |
1.66 |
447,757 |
742,023 |
4,998,493 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 12 '26 |
Sale |
1.66 |
127,544 |
211,366 |
1,040,551 |
| Benjamin Richard J | Chief Medical Officer |
Mar 12 '26 |
Sale |
1.66 |
101,740 |
168,604 |
777,361 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 05 '26 |
Sale |
2.06 |
55,225 |
113,902 |
1,195,891 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 06 '26 |
Sale |
2.01 |
27,796 |
55,745 |
1,168,095 |
| Benjamin Richard J | Chief Medical Officer |
Mar 05 '26 |
Sale |
2.06 |
61,233 |
126,305 |
943,762 |
| Benjamin Richard J | Chief Medical Officer |
Mar 09 '26 |
Sale |
1.88 |
40,426 |
76,029 |
879,101 |
| Benjamin Richard J | Chief Medical Officer |
Mar 06 '26 |
Sale |
2.01 |
24,235 |
48,603 |
919,527 |
| Jensen Chrystal | Chief Legal Officer |
Mar 06 '26 |
Sale |
2.01 |
30,845 |
61,860 |
1,059,139 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 06 '26 |
Sale |
2.01 |
34,094 |
68,376 |
1,912,874 |
0.57%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):